Theranica, a Netanya-based company developing advanced electroceuticals for migraine and other pain conditions, announced Thursday that its Nerivio therapeutic wearable has been selected as the winner of the "Best New Technology Solution for Pain Management" award in the fifth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough.
Follow Israel Hayom on Facebook and Twitter
This year's program attracted more than 3,850 nominations from over 17 different countries throughout the world.
"Migraine is the third most prevalent disorder in the world and affects approximately 1 billion people," said James Johnson, managing director, MedTech Breakthrough.
"Nerivio addresses this challenging condition by encompassing the best elements of MedTech solutions, including a true digital health non-invasive treatment approach that deploys an innovative mechanism of action and an accompanying app that controls the device while enabling patients to track and manage their migraines."
Nerivio is a first-line drug-free migraine treatment that deploys remote electrical neuromodulation to activate the body's native conditioned pain modulation mechanism to treat headache and other symptoms associated with migraine. The treatment is personalized through the Nerivio app (available for iPhone and Android), which also includes an interactive migraine diary to track treatment sessions and symptoms.
"A true advancement in digital health, Nerivio is changing the traditional migraine treatment paradigm and will continue to positively impact patients, by providing pain relief and enabling people get back to life," said Theranica co-founder and CEO Alon Ironi.
